Channels - Allergic contact dermatitis to a mobile phone screen protector :: FRELIP Discovery

Similar Items: Allergic contact dermatitis to a mobile phone screen protector

Quick Look
Corticosteroid Phobia in Patients with Atopic Dermatitis: A Narrative Review
Quick Look
An 11‐Month‐Old Infant With Unusual Diaper Dermatitis
Quick Look
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
Quick Look
Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck Region
Quick Look
The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review
Quick Look
Blistering Beetle Dermatitis Mimicking Herpes Zoster Ophthalmicus: a Case Report
Quick Look
Review on the Application of Biologic Factors in Atopic Dermatitis and Chronic Spontaneous Urticaria
Quick Look
Topical Corticosteroid Phobia in Childhood Atopic Dermatitis: A Study Using the TOPICOP Score
Quick Look
Do Medication Beliefs Influence Adherence to Topical Therapies in Patients With Atopic Dermatitis?
Quick Look
Mental Health Among Caregivers of Children With Atopic Dermatitis: A Systematic Review With Meta‐Analysis
Quick Look
Evolving Research Hotspots and Emerging Trends in Atopic Dermatitis and Inflammatory Bowel Disease: A Bibliometric Analysis
Quick Look
Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study
Quick Look
Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature
Quick Look
Rapid Improvement of Acute Eczematous Facial Dermatitis During Pregnancy Following Stapokibart Therapy: A Case Report
Quick Look
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
Quick Look
Clinical Features and Risk Factors of Dermatitis Cruris Pustulosa et Atrophicans in Southwestern Uganda: A Cross-Sectional Study
Quick Look
Optimizing Abrocitinib Use for Atopic Dermatitis in India: Expert Recommendations for Patient Selection, Dosing, and Long‑Term Remission
Quick Look
Incidence of Skin Infections in Patients with Atopic Dermatitis Treated with Topical Medications: A Cohort Study Using Japanese Claims Data
Quick Look
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
Quick Look
Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
Quick Look
Biochemical Mechanisms Mediating the Immunomodulatory and Anti-Atopic Dermatitis Effects of GammaQ in a DNCB-Induced BALB/c Mouse Model
Quick Look
Corrigendum to “Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”
Quick Look
REVEAL AD ‐ Prevalence of Moderate and Severe Atopic Dermatitis in Ireland: A Cross‐ Sectional, Real World Study of a Secondary Care Population
Quick Look
Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17A